
|Articles|July 9, 1997
FDA clears Siemens Opdima unit
Siemens Medical Systems has received 510(k) clearance from the Food and Drug Administration for its Opdima digital spot mammography unit. Opdima is based on charge-coupled device (CCD) technology and retrofits to the Iselin, NJ, vendor's Mammomat 3000
Advertisement
Siemens Medical Systems has received 510(k) clearance from the Food and Drug Administration for its Opdima digital spot mammography unit. Opdima is based on charge-coupled device (CCD) technology and retrofits to the Iselin, NJ, vendor's Mammomat 3000 mammography system. It has a field-of-view of 49 x 85 mm, which Siemens claims is the largest in the industry among digital spot devices. Siemens launched Opdima in Europe in April (SCAN 4/30/97).
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
How AI-Enabled Enterprise Imaging is Improving the Quality and Access to Timely Care for Patients with Acute Stroke
2
Emerging Research in Mammography, Breast MRI, Ultrasound and AI: A Summer Roundup of Key Breast Imaging Studies
3
Top Five Radiology Content in August 2026
4
CCTA-Derived Fractional Flow Reserve Facilitates 44 Percent Reduction in ICA Procedures for Patients with Obstructive Stenosis
5















